封面
市场调查报告书
商品编码
1363034

生物製药辅料市场规模、份额和趋势分析报告:2023-2030 年按产品、地区和细分市场分類的趋势

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product (Polyols, Solubilizes & Surfactants/Emulsifiers, Carbohydrates, Specialty Excipients), By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

生物製药辅料市场成长与趋势:

Grand View Research, Inc. 的最新报告显示,到 2030 年,全球生物製药辅料市场规模预计将达到 37.6 亿美元。

预计2023年至2030年该市场将以5.50%的年复合成长率扩张。製药公司对仿製药市场的日益关注、多功能赋形剂的日益采用以及生物活性物质的专利到期是推动市场成长的主要要素。此外,製造商的成本效率和能力、生物製药的化学和物理不稳定性正在促进辅料的开发并推动市场。

近年来,生物相似药的需求增加,导致生物製药辅料的需求增加。专利到期、政府资助增加、患者人口统计和负担能力上升等支持要素正在推动生物相似药在世界各地的采用。此外,新兴经济体医疗保健基础设施的快速发展增加了生物相似药在生物相似药生产中的使用。此外,全球范围内引入更好的立法以确保生物相似药有适当的法规和测试标准,这使得製造商更容易进入市场。

此外,工业界对多功能生物製药辅料的接受度不断提高也推动了市场的成长。多功能生物製药辅料可高效能有效增强生物製药製造製程。相关的好处包括提高产品品质、提高生产力和降低营运成本。 COVID-19 疫苗的成功高度依赖效率,而透过使用高效的药物输送系统可以提高效率。

市场主要参与者专注于新型生物製药辅料的开发和行销。例如,2021年4月,DFE Pharma推出了新的辅料产品线“BioHale”,以应对生物製药公司的全球供应挑战。此外,对生物製药辅料不断增长的需求正在增加生产设施的地理扩张。例如,2022年5月,DFE Pharma 在印度开设了一家新工厂,提供快速配方服务,包括辅料,帮助製药公司实现正确的配方。

然而,生物製药行业的供应链问题和生技药品辅料市场开拓的挑战预计将在预测期内阻碍市场。为生物製药选择合适的赋形剂是一项困难而复杂的挑战,因为在一种製剂中有效的赋形剂可能会导致另一种製剂中的蛋白质降解或聚集。已知和核准的蛋白质稳定产品数量有限,进一步加剧了生物製药製造商面临的挑战。因此,为了应对这些挑战,研究人员正在开发新的创新方法。例如,为了维持脂质赋形剂(HMC赋形剂)的稳定性,研究人员应用了脂肪酸聚甘油酯(PGFA)。目前,在 COVID-19 疫苗的开发中,对这些产品的需求不断增加。

生物製药辅料市场报告亮点:

  • 碳水化合物产品领域在生物製药辅料市场占据主导地位,到 2022 年收益占有率将达到 35.80%,预计这一趋势将在预测期内持续下去。淀粉、蔗糖和葡萄糖在各种药物製剂中的广泛使用被认为是它们在这一领域占据主导地位的要素。
  • 多元醇领域预计在预测期内年复合成长率5.77%。多元醇是存在于某些水果、蔬菜和无糖甜味剂中的糖醇。该领域的成长是由蛋白质治疗药物需求的增加所推动的。将多元醇添加到蛋白质配方中以增加张力和稳定性。
  • 按地区划分,2022年北美在生物製药辅料市场中占据最高份额。该地区的成长可归因于多种要素,包括主要企业的存在、药物开发的增加和人口众多。该地区的公司经常合作开发生物製药辅料。
  • 由于参与药物开发的主要 CMO 的存在,预计亚太地区在预测期内将出现超过 6.0% 的快速成长。中国、印度和韩国等国大力参与生物相似药的开发。生物相似药在该地区广泛开发有几个原因,包括负担能力、有利的法律规范、成本优势和庞大的人口基数。例如,

目录

第1章生物製药辅料市场:调查方法与范围

第2章生物製药辅料市场:执行摘要

  • 市场预测
  • 产品简介
  • 竞争形势概览

第3章生物製药辅料市场:市场变数、趋势与范围

  • 市场体系预测
  • 市场动态
  • 产业分析工具

第4章生物製药辅料市场:产品商业分析

  • 生物製药辅料市场:产品变异分析
  • 增溶剂和介面活性剂/乳化剂
  • 多元醇
  • 碳水化合物
  • 特殊辅料

第5章生物製药辅料市场:区域商业分析

  • 区域市场概述
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第6章生物製药辅料市场:竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介

第7章KOL推荐/分析师观点

Product Code: GVR-3-68038-006-4

Biopharmaceutical Excipients Market Growth & Trends:

The global biopharmaceutical excipients market size is expected to reach USD 3.76 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 5.50% from 2023 to 2030. The increasing focus of pharmaceutical players on the generic market, rising adoption of multifunctional excipients, and patent expiry of biological actives are the key factors propelling market growth. Furthermore, the cost-efficiency & competency of manufacturers and the chemical and physical instability of biopharmaceuticals are boosting the development of excipients, thus propelling the market.

The demand for biosimilars has increased in recent years, which has in turn led to a rise in the demand for biopharmaceutical excipients. Supporting factors such as patent expirations, increasing government funding, patient demographics, and rising affordability have propelled the adoption of biosimilars across the globe. In addition, the rapidly evolving healthcare infrastructure in developing economies has increased their use in the production of biogenerics. Furthermore, the introduction of well-framed legislation to ensure proper regulatory and testing standards for biosimilars globally is set to ease market entry for manufacturers.

Moreover, the growing acceptance of multi-functional biopharmaceutical excipients in industries is also driving market growth. They are efficient and effective in enhancing the manufacturing process for biopharmaceuticals. Associated advantages include better product quality, improved productivity, and reduced operating costs. The success of COVID-19 vaccines majorly relies on their efficiency, which has been enhanced by using efficient drug delivery systems; this offers immense lucrative opportunities for market entities.

Key operating players in the market are focusing on the development and launch of novel biopharmaceutical excipients. For instance, in April 2021, DFE Pharma introduced a new excipient product line 'BioHale' to address global supply challenges for biopharmaceutical companies. Furthermore, the geographical expansion of manufacturing facilities is increasing, owing to the rising demand for biopharmaceutical excipients. For instance, in May 2022, DFE Pharma opened a new facility in India to offer fast-track formulation services, including excipients, for pharmaceutical players to achieve the right formulations.

However, issues pertaining to the supply chain in the biopharmaceutical industry and challenges in the development of excipients for biologics are expected to hamper the market during the forecast period. Selecting the right excipient for biopharmaceuticals is a challenging and complicated task, as an excipient effective in one formulation may cause degradation or aggregation of the protein in another. A limited number of known & approved products for the stabilization of protein further increases challenges for biopharma manufacturers. Hence, to deal with these challenges, researchers are developing new and innovative approaches. For instance, to maintain the stability of lipid-based excipients (HMC excipients), researchers have applied polyglycerol esters of fatty acids (PGFAs). Currently, these products are witnessing an increasing demand for the development of COVID-19 vaccines.

Biopharmaceutical Excipients Market Report Highlights:

  • Thecarbohydrate-based products segment dominated the market for biopharmaceutical excipients in 2022 with a revenue share of 35.80%, and this trend is expected to continue through the forecast period. The extensive use of starch, sucrose, and dextrose in various drug formulations can be primarily attributed to the dominant share of the segment
  • The polyols segment is expected to witness the fastest CAGR of 5.77% during the projection period. Polyols are sugar alcohols found in certain fruits, vegetables, and sugar-free sweeteners. The segment growth can be attributed to the increasing demand for protein therapeutics. Polyols are added in protein formulations for increasing tonicity and stability
  • In terms of region, North America held the highest share in the market for biopharmaceutical excipients in 2022.The regional growth can be attributed to several factors such as the presence of key players, increasing drug development, and a large population base. Companies in this region are collaborating frequently to develop biopharmaceutical excipients
  • In Asia Pacific, the market is expected to witness the fastest growth rate of over 6.0% during the forecast period, owing to the presence of large CMOs involved in drug development in the region. Countries such as China, India, and South Korea are majorly involved in the development of biosimilars. There are several reasons for the extensive development of biosimilars in this region, such as affordability, favorable regulatory framework, cost advantages, and the presence of a large population base

Table of Contents

Chapter 1 Biopharmaceutical Excipients Market: Research Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Product Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List of Secondary Sources
  • 1.11 List of Abbreviations

Chapter 2 Biopharmaceutical Excipients Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Product Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Biopharmaceutical Excipients Market: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Chemical And Physical Instability Of Biopharmaceuticals Is Boosting The Development Of Excipients
      • 3.2.1.2 Increase In Focus Of Pharmaceutical Players On Biogeneric Market
      • 3.2.1.3 Cost Effective And Competency Of Manufacturers
      • 3.2.1.4 Patent Expiry Of Biological Actives
      • 3.2.1.5 Rising Adoption Of Multifunctional Excipients
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 Challenges In Development Of Excipients For Biologics
      • 3.2.2.2 Issues Pertaining To Supply Chain In Biopharmaceutical Industry
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis

Chapter 4 Biopharmaceutical Excipients Market: Product Business Analysis

  • 4.1 Biopharmaceutical Excipients Market: Product Movement Analysis
  • 4.2 Solubilizes & Surfactants/Emulsifiers
    • 4.2.1 Solubilizes & Surfactants/Emulsifiers Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.2 Triglycerides
      • 4.2.2.1 Triglycerides Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.3 Esters
      • 4.2.3.1 Esters Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.2.4 Others
      • 4.2.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.3 Polyols
    • 4.3.1 Polyols Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.2 Mannitol
      • 4.3.2.1 Mannitol Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.3 Sorbitol
      • 4.3.3.1 Sorbitol Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.3.4 Others
      • 4.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.4 Carbohydrates
    • 4.4.1 Carbohydrates Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.2 Dextrose
      • 4.4.2.1 Dextrose Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.3 Sucrose
      • 4.4.3.1 Sucrose Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.4 Starch
      • 4.4.4.1 Starch Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 4.4.5 Others
      • 4.4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
  • 4.5 Specialty Excipients
    • 4.5.1 Specialty Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)

Chapter 5 Biopharmaceutical Excipients Market: Regional Business Analysis

  • 5.1 Regional Market Snapshot
  • 5.2 North America
    • 5.2.1 North America Biopharmaceutical Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.2.2 U.S.
      • 5.2.2.1 U.S. Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.2.2.2 Key Country Dynamics
      • 5.2.2.3 Regulatory Framework
      • 5.2.2.4 Reimbursement Scenario
    • 5.2.3 Canada
      • 5.2.3.1 Canada Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.2.3.2 Key Country Dynamics
      • 5.2.3.3 Regulatory Framework
      • 5.2.3.4 Reimbursement Scenario
  • 5.3 Europe
    • 5.3.1 Europe Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.3.2 UK
      • 5.3.2.1 UK Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.2.2 Key Country Dynamics
      • 5.3.2.3 Regulatory Framework
      • 5.3.2.4 Reimbursement Scenario
    • 5.3.3 Germany
      • 5.3.3.1 Germany Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.3.2 Key Country Dynamics
      • 5.3.3.3 Regulatory Framework
      • 5.3.3.4 Reimbursement Scenario
    • 5.3.4 Spain
      • 5.3.4.1 Spain Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.4.2 Key Country Dynamics
      • 5.3.4.3 Regulatory Framework
      • 5.3.4.4 Reimbursement Scenario
    • 5.3.5 France
      • 5.3.5.1 France Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.5.2 Key Country Dynamics
      • 5.3.5.3 Regulatory Framework
      • 5.3.5.4 Reimbursement Scenario
    • 5.3.6 Italy
      • 5.3.6.1 Italy Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.6.2 Key Country Dynamics
      • 5.3.6.3 Regulatory Framework
      • 5.3.6.4 Reimbursement Scenario
    • 5.3.7 Denmark
      • 5.3.7.1 Denmark Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.7.2 Key Country Dynamics
      • 5.3.7.3 Regulatory Framework
      • 5.3.7.4 Reimbursement Scenario
    • 5.3.8 Sweden
      • 5.3.8.1 Sweden Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.8.2 Key Country Dynamics
      • 5.3.8.3 Regulatory Framework
      • 5.3.8.4 Reimbursement Scenario
    • 5.3.9 Norway
      • 5.3.9.1 Norway Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.3.9.2 Key Country Dynamics
      • 5.3.9.3 Regulatory Framework
      • 5.3.9.4 Reimbursement Scenario
  • 5.4 Asia Pacific
    • 5.4.1 Asia-Pacific Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.4.2 Japan
      • 5.4.2.1 Japan Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.2.2 Key Country Dynamics
      • 5.4.2.3 Regulatory Framework
      • 5.4.2.4 Reimbursement Scenario
    • 5.4.3 CHINA
      • 5.4.3.1 China Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.3.2 Key Country Dynamics
      • 5.4.3.3 Regulatory Framework
      • 5.4.3.4 Reimbursement Scenario
    • 5.4.4 India
      • 5.4.4.1 India Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.4.2 Key Country Dynamics
      • 5.4.4.3 Regulatory Framework
      • 5.4.4.4 Reimbursement Scenario
    • 5.4.5 South Korea
      • 5.4.5.1 South Korea Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.5.2 Key Country Dynamics
      • 5.4.5.3 Regulatory Framework
      • 5.4.5.4 Reimbursement Scenario
    • 5.4.6 Thailand
      • 5.4.6.1 Thailand Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.6.2 Key Country Dynamics
      • 5.4.6.3 Regulatory Framework
      • 5.4.6.4 Reimbursement Scenario
    • 5.4.7 Australia
      • 5.4.7.1 Australia Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.4.7.2 Key Country Dynamics
      • 5.4.7.3 Regulatory Framework
      • 5.4.7.4 Reimbursement Scenario
  • 5.5 Latin America
    • 5.5.1 Latin America Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.5.2 Brazil
      • 5.5.2.1 Brazil Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.2.2 Key Country Dynamics
      • 5.5.2.3 Regulatory Framework
      • 5.5.2.4 Reimbursement Scenario
    • 5.5.3 Mexico
      • 5.5.3.1 Mexico Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.3.2 Key Country Dynamics
      • 5.5.3.3 Regulatory Framework
      • 5.5.2.4 Reimbursement Scenario
    • 5.5.4 Argentina
      • 5.5.4.1 Argentina Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.5.4.2 Key Country Dynamics
      • 5.5.4.3 Regulatory Framework
      • 5.5.4.4 Reimbursement Scenario
  • 5.6 MEA
    • 5.6.1 MEA Biopharmaceutical Excipients Market 2018 - 2030 (USD Million) (Volume In Tons)
    • 5.6.2 South Africa
      • 5.6.2.1 South Africa Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.2.2 Key Country Dynamics
      • 5.6.2.3 Regulatory Framework
      • 5.6.2.4 Reimbursement Scenario
    • 5.6.3 Saudi Arabia
      • 5.6.3.1 Saudi Arabia Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.3.2 Key Country Dynamics
      • 5.6.3.3 Regulatory Framework
      • 5.6.3.4 Reimbursement Scenario
    • 5.6.4 UAE
      • 5.6.4.1 UAE Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.4.2 Key Country Dynamics
      • 5.6.4.3 Regulatory Framework
      • 5.6.2.4 Reimbursement Scenario
    • 5.6.5 Kuwait
      • 5.6.5.1 Kuwait Biopharmaceutical Excipients Market, 2018 - 2030 (USD Million) (Volume In Tons)
      • 5.6.5.2 Key Country Dynamics
      • 5.6.5.3 Regulatory Framework
      • 5.6.5.4 Reimbursement Scenario

Chapter 6 Biopharmaceutical Excipients Market: Competitive Landscape

  • 6.1 Company Categorization
  • 6.2 Strategy Mapping
    • 6.2.1 New product launch
    • 6.2.2 Partnerships
    • 6.2.3 Acquisition
    • 6.2.4 Collaboration
    • 6.2.5 Funding
  • 6.3 Company Market Share Analysis, 2022
  • 6.4 Company Profiles
    • 6.4.1 MERCK KGAA
      • 6.4.1.1 Company overview
      • 6.4.1.2 Financial performance
      • 6.4.1.3 Product benchmarking
      • 6.4.1.4 Strategic initiatives
    • 6.4.2 SIGNET EXCIPIENTS PVT. LTD.
      • 6.4.2.1 Company overview
      • 6.4.2.2 Financial performance
      • 6.4.2.3 Product benchmarking
      • 6.4.2.4 Strategic initiatives
    • 6.4.3 Sigachi Industries Pvt. Ltd
      • 6.4.3.1 Company overview
      • 6.4.3.2 Financial performance
      • 6.4.3.3 Product benchmarking
      • 6.4.3.4 Strategic initiatives
    • 6.4.4 ASSOCIATED BRITISH FOODS
      • 6.4.4.1 Company overview
      • 6.4.4.2 Financial performance
      • 6.4.4.3 Product benchmarking
      • 6.4.4.4 Strategic initiatives
    • 6.4.5 SPECTRUM CHEMICAL MANUFACTURING CORP.
      • 6.4.5.1 Company overview
      • 6.4.5.2 Financial performance
      • 6.4.5.3 Product benchmarking
      • 6.4.5.4 Strategic initiatives
    • 6.4.6 ROQUETTE FRERES
      • 6.4.6.1 Company overview
      • 6.4.6.2 Financial performance
      • 6.4.6.3 Product benchmarking
      • 6.4.6.4 Strategic initiatives
    • 6.4.7 DFE PHARMA
      • 6.4.7.1 Company overview
      • 6.4.7.2 Financial performance
      • 6.4.7.3 Product benchmarking
      • 6.4.7.4 Strategic initiatives
    • 6.4.8 CLARIANT
      • 6.4.8.1 Company overview
      • 6.4.8.2 Financial performance
      • 6.4.8.3 Product benchmarking
      • 6.4.8.4 Strategic initiatives
    • 6.4.9 COLORCON
      • 6.4.9.1 Company overview
      • 6.4.9.2 Financial performance
      • 6.4.9.4 Product benchmarking
      • 6.4.9.5 Strategic initiatives
    • 6.4.10 RETTENMAIER & SOHNE GMBH + CO KG
      • 6.4.10.1 Company overview
      • 6.4.10.2 Financial performance
      • 6.4.10.3 Product benchmarking
      • 6.4.10.4 Strategic initiatives
    • 6.4.11 BASF SE
      • 6.4.11.1 Company overview
      • 6.4.11.2 Financial performance
      • 6.4.11.3 Product benchmarking
      • 6.4.11.4 Strategic initiatives
    • 6.4.12 EVONIK INDUSTRIES AG
      • 6.4.12.1 Company overview
      • 6.4.12.2 Financial performance
      • 6.4.12.3 Product benchmarking
      • 6.4.12.4 Strategic initiatives
    • 6.4.13 IMCD
      • 6.4.12.1 Company overview
      • 6.4.12.2 Financial performance
      • 6.4.12.3 Product benchmarking
      • 6.4.12.4 Strategic initiatives

Chapter 7 KOL Recommendations/Analyst Perspective

List of Tables

  • TABLE 1 Primary interview details: North America
  • TABLE 2 Primary interview details: Europe
  • TABLE 3 Primary interview details: APAC
  • TABLE 4 Primary interview details: Latin America
  • TABLE 5 Primary interview details: MEA
  • TABLE 6 List of secondary sources
  • TABLE 7 List of top 10 drugs in 2020 by sales
  • TABLE 8 Chemically reactive oxidation products formed by use of Polysorbate 80
  • TABLE 9 The frequency of inclusion of polyols in mAb formulations (%)
  • TABLE 10 North America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 11 North America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 12 North America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 13 North America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 14 North America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 15 North America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 16 North America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 17 North America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 18 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 20 U.S. Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 21 U.S. Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 22 U.S. polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 23 U.S. polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 24 U.S. carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 25 U.S. carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 26 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 27 Canada biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 28 Canada Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 29 Canada Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 30 Canada polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 31 Canada polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 32 Canada carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 33 Canada carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 34 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 35 Europe biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 36 Europe Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 37 Europe Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 38 Europe polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 39 Europe polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 40 Europe carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 41 Europe carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 42 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 43 Germany biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 44 Germany Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 45 Germany Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 46 Germany polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 47 Germany polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 48 Germany carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 49 Germany carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 50 UK biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 51 UK biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 52 UK Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 53 UK Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 54 UK polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 55 UK polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 56 UK carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 57 UK carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 58 France biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 59 France biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 60 France Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 61 France Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 62 France polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 63 France polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 64 France carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 65 France carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 66 Italy biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 67 Italy biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 68 Italy Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 69 Italy Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 70 Italy polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 71 Italy polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 72 Italy carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 73 Italy carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 74 Spain biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 75 Spain biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 76 Spain Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 77 Spain Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 78 Spain polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 79 Spain polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 80 Spain carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 81 Spain carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 82 Denmark biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 83 Denmark biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 84 Denmark Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 85 Denmark Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 86 Denmark polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 87 Denmark polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 88 Denmark carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 89 Denmark carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 90 Sweden biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 91 Sweden biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 92 Sweden Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 93 Sweden Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 94 Sweden polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 95 Sweden polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 96 Sweden carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 97 Sweden carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 98 Norway biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 99 Norway biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 100 Norway Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 101 Norway Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 102 Norway polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 103 Norway polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 104 Norway carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 105 Norway carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 106 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 107 Asia Pacific biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 108 Asia Pacific Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 109 Asia Pacific Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 110 Asia Pacific polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 111 Asia Pacific polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 112 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 113 Asia Pacific carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 114 Top selling biopharmaceuticals in Japan: 2020
  • TABLE 115 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 116 Japan biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 117 Japan Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 118 Japan Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 119 Japan polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 120 Japan polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 121 Japan carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 122 Japan carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 123 China biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 124 China biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 125 China Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 126 China Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 127 China polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 128 China polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 129 China carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 130 China carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 131 India biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 132 India biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 133 India Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 134 India Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 135 India polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 136 India polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 137 India carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 138 India carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 139 Thailand biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 140 Thailand biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 141 Thailand Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 142 Thailand Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 143 Thailand polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 144 Thailand polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 145 Thailand carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 146 Thailand carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 147 South Korea: Approved Biosimilars
  • TABLE 148 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 149 South Korea biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 150 South Korea Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 151 South Korea Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 152 South Korea polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 153 South Korea polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 154 South Korea carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 155 South Korea carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 156 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 157 Australia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 158 Australia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 159 Australia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 160 Australia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 161 Australia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 162 Australia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 163 Australia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 164 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 165 Latin America biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 166 Latin America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 167 Latin America Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 168 Latin America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 169 Latin America polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 170 Latin America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 171 Latin America carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 172 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 173 Brazil biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 174 Brazil Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 175 Brazil Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 176 Brazil polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 177 Brazil polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 178 Brazil carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 179 Brazil carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 180 Mexico biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 181 Mexico biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 182 Mexico Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 183 Mexico Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 184 Mexico polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 185 Mexico polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 186 Mexico carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 187 Mexico carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 188 Argentina biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 189 Argentina biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 190 Argentina Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 191 Argentina Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 192 Argentina polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 193 Argentina polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 194 Argentina carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 195 Argentina carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 196 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 197 Middle East & Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 198 Middle East & Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 199 Middle East & Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 200 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 201 Middle East & Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 202 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 203 Middle East & Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 204 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 205 South Africa biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 206 South Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 207 South Africa Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 208 South Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 209 South Africa polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 210 South Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 211 South Africa carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 212 Saudi Arabia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 213 Saudi Arabia biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 214 Saudi Arabia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 215 Saudi Arabia Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 216 Saudi Arabia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 217 Saudi Arabia polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 218 Saudi Arabia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 219 Saudi Arabia carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 220 UAE biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 221 UAE biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 222 UAE Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 223 UAE Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 224 UAE polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 225 UAE polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 226 UAE carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 227 UAE carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 228 Kuwait biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (USD Million)
  • TABLE 229 Kuwait biopharmaceutical excipients market estimates & forecasts, by product, 2018 - 2030 (Volume in Tons)
  • TABLE 230 Kuwait Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 231 Kuwait Solubilizes & surfactants/emulsifiers excipient market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 232 Kuwait polyol excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 233 Kuwait polyol excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)
  • TABLE 234 Kuwait carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • TABLE 235 Kuwait carbohydrate excipients market estimates & forecasts, by type, 2018 - 2030 (Volume in Tons)

List of Figures

  • FIG. 1 Market snapshot
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Commodity flow analysis
  • FIG. 10 Volume price analysis
  • FIG. 11 Market trends & outlook
  • FIG. 12 Market segmentation & scope
  • FIG. 13 Market driver relevance analysis (Current & future impact)
  • FIG. 14 Market restraint relevance analysis (Current & future impact)
  • FIG. 15 Penetration & growth prospect mapping for products, 2020
  • FIG. 16 SWOT Analysis, By Factor (political & legal, economic, and technological)
  • FIG. 17 Porter's Five Forces Analysis
  • FIG. 18 Global biopharma excipients market: Product outlook key takeaways
  • FIG. 19 Biopharma excipients market: Product movement analysis
  • FIG. 20 Global solubilizes & surfactants/emulsifiers market, by revenue 2018 - 2030 (USD Million)
  • FIG. 21 Global solubilizes & surfactants/emulsifiers market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 22 Global triglycerides market, by revenue 2018 - 2030 (USD Million)
  • FIG. 23 Global triglycerides market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 24 Global esters market, by revenue 2018 - 2030 (USD Million)
  • FIG. 25 Global esters market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 26 Global other Solubilizes market, by revenue 2018 - 2030 (USD Million)
  • FIG. 27 Global other Solubilizes market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 28 Global polyols market, by revenue 2018 - 2030 (USD Million)
  • FIG. 29 Global polyols market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 30 Global mannitol market, by revenue 2018 - 2030 (USD Million)
  • FIG. 31 Global mannitol market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 32 Global sorbitol market, by revenue 2018 - 2030 (USD Million)
  • FIG. 33 Global sorbitol market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 34 Global other polyols market, by revenue 2018 - 2030 (USD Million)
  • FIG. 35 Global other polyols market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 36 Global carbohydrates market, by revenue 2018 - 2030 (USD Million)
  • FIG. 37 Global carbohydrates market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 38 Global dextrose market, by revenue 2018 - 2030 (USD Million)
  • FIG. 39 Global dextrose market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 40 Global sucrose market, by revenue 2018 - 2030 (USD Million)
  • FIG. 41 Global sucrose market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 42 Global starch market, by revenue 2018 - 2030 (USD Million)
  • FIG. 43 Global starch market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 44 Global other carbohydrates market, by revenue 2018 - 2030 (USD Million)
  • FIG. 45 Global other carbohydrates market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 46 Global specialty excipients market, by revenue 2018 - 2030 (USD Million)
  • FIG. 47 Global specialty excipients market, by volume 2018 - 2030 (Volume in Tons)
  • FIG. 48 Regional market place: Key takeaway
  • FIG. 49 Biopharmaceutical excipients regional outlook, 2018 & 2030
  • FIG. 50 North America biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 51 U.S. biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 52 Canada biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 53 Europe biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 54 Germany biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 55 UK biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 56 France biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 57 Italy biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 58 Spain biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 59 Denmark biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 60 Sweden biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 61 Norway biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 62 Asia Pacific biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 63 Japan biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 64 China biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 65 India biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 66 Thailand biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 67 South Korea biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 68 Australia biopharmaceutical excipients market, by revenue 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 69 Latin America biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 70 Brazil biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 71 Mexico biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 72 Argentina biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 73 Middle East & Africa biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 74 South Africa biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 75 Saudi Arabia biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 76 UAE biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 77 Kuwait biopharmaceutical excipients market, 2018 - 2030 (USD Million) (Volume in Tons)
  • FIG. 78 Strategy framework
  • FIG. 79 Participant categorization